Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients
Gastroenterology Research and Practice · 06.04.2021 · 2021 · 1-11
DOI: 10.1155/2021/8886525 ↗Kurz gefasst
Fachartikel in der Zeitschrift Gastroenterology Research and Practice, erschienen am 06.04.2021. Verfasst von Panu Wetwittayakhlang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Faculty of Medicine, Prince of Songkla University.
Abstract (Originalsprache)
Background and Aims. Tissue-invasive gastrointestinal cytomegalovirus (TI-GI CMV) disease is common in immunocompromised patients, but the increasing prevalence in immunocompetent patients has been reported. This study compared the clinical manifestations, endoscopic features, treatment outcomes, and predictors for inhospital mortality of TI-GI CMV between immunocompromised and immunocompetent patients.
Methods
Patients with HIV infection, malignancy, or receiving immunosuppressive agents (chemotherapy, high dose, or long-term corticosteroids) were defined as the immunocompromised group. Demographic and inhospital mortality data were obtained and retrospectively analyzed.
Results
A total of 213 patients (89 immunocompetent) with histologically confirmed TI-GI CMV were enrolled. Immunocompetent patients were older (70 vs. 52 years; p < 0.001 ), had more GI bleeding as a presenting symptom (47.2% vs. 29.0%; p = 0.010 ), and shorter symptom onset (2 vs. 14 days, p = 0.018 ). Concomitant extra-GI involvement was only seen in the immunocompromised group (6.5% vs. 0%; p = 0.02 ). Diffuse GI tract (14.5% vs. 4.5%; p = 0.032 ) and esophageal involvement (14.5% vs. 5.6%; p = 0.046 ) were more frequent in the immunocompromised, while small bowel involvement was more frequent in the immunocompetent group (19.1% vs. 8.1%; p = 0.029 ). An overall inhospital mortality was 27.7%. There was no significant difference in inhospital survival probability between the two groups (Peto-Peto test, p = 0.65 ). ICU admission (hazard ratio [HR] 7.21; 95% CI 2.55-20.36), sepsis or shock (HR 1.98; 95% CI 1.08-3.66), malnutrition (HR 2.62; 95% CI 1.05-7.01), and receiving chemotherapy (HR 5.2; 95% CI 1.89-14.29) were independent factors for inhospital mortality. Antiviral treatment for more than 14 days was the only protective factor to improve survival (Peto-Peto test, p < 0.001 ).
Conclusions
Immunocompetent and immunocompromised patients with TI-GI CMV disease had distinct clinical and endoscopic characteristics. There was no significant difference in the inhospital mortality between the two groups. The factors for mortality were ICU admission, sepsis/shock, malnutrition, and receiving chemotherapy. Early diagnosis and initiation of antiviral treatment might improve the survival probability.
Autor:innen und Institutionen
- Gastroenterology and Hepatology Unit, Division of Internal Medicine, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
- Division of Pathology, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
- Epidemiology Unit, Faculty of Medicine, Prince of Songkla University, Songkhla 90110, Thailand.
- NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital, Prince of Songkla University, Hat Yai, Songkla 90110, Thailand.
ORCID-Profile: Panu Wetwittayakhlang, Pimsiri Sripongpun
Förderung
- NKC Institute of Gastroenterology and Hepatology, Songklanagarind Hospital
- Faculty of Medicine, Prince of Songkla University
Zitieren
APA
Wetwittayakhlang, P., Rujeerapaiboon, N., Wetwittayakhlung, P., Sripongpun, P., Pruphetkaew, N., Jandee, S., Chamroonkul, N., & Piratvisuth, T. (2021). Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients. Gastroenterology Research and Practice, 2021, 1-11. https://doi.org/10.1155/2021/8886525
Vancouver
Wetwittayakhlang P, Rujeerapaiboon N, Wetwittayakhlung P, Sripongpun P, Pruphetkaew N, Jandee S, et al. Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients. Gastroenterology Research and Practice. 2021;2021:1-11. doi:10.1155/2021/8886525
BibTeX
@article{Wetwittayakhlang2021,
author = {Wetwittayakhlang, Panu and Rujeerapaiboon, Natthapat and Wetwittayakhlung, Poowadon and Sripongpun, Pimsiri and Pruphetkaew, Nannapat and Jandee, Sawangpong and Chamroonkul, Naichaya and Piratvisuth, Teerha},
title = {Clinical Features, Endoscopic Findings, and Predictive Factors for Mortality in Tissue-Invasive Gastrointestinal Cytomegalovirus Disease between Immunocompetent and Immunocompromised Patients},
journal = {Gastroenterology Research and Practice},
year = {2021},
volume = {2021},
pages = {1--11},
doi = {10.1155/2021/8886525}
}
EUVIMED